U.S. Markets closed
  • S&P Futures

    4,069.75
    -12.00 (-0.29%)
     
  • Dow Futures

    34,347.00
    -82.00 (-0.24%)
     
  • Nasdaq Futures

    12,016.50
    -46.25 (-0.38%)
     
  • Russell 2000 Futures

    1,877.90
    -5.80 (-0.31%)
     
  • Crude Oil

    81.01
    -0.21 (-0.26%)
     
  • Gold

    1,814.20
    -1.00 (-0.06%)
     
  • Silver

    22.85
    +0.01 (+0.06%)
     
  • EUR/USD

    1.0516
    -0.0012 (-0.1157%)
     
  • 10-Yr Bond

    3.5290
    -0.1740 (-4.70%)
     
  • Vix

    19.84
    -0.74 (-3.60%)
     
  • GBP/USD

    1.2241
    -0.0016 (-0.1285%)
     
  • USD/JPY

    135.3350
    +0.0290 (+0.0214%)
     
  • BTC-USD

    17,008.02
    -133.83 (-0.78%)
     
  • CMC Crypto 200

    403.53
    -2.62 (-0.65%)
     
  • FTSE 100

    7,558.49
    -14.56 (-0.19%)
     
  • Nikkei 225

    27,822.18
    -403.90 (-1.43%)
     

New Strong Sell Stocks for March 1st

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Agios Pharmaceuticals AGIO: is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases. The Zacks Consensus Estimate for its current year earnings has been revised 26.6% downward over the last 60 days.

Alimera Sciences ALIM: is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Zacks Consensus Estimate for its current year earnings has been revised 302.1% downward over the last 60 days.

BrightView (BV): is a provider of commercial landscaping services primarily in the United States. The Zacks Consensus Estimate for its current year earnings has been revised almost 7.4% downward over the last 60 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alimera Sciences, Inc. (ALIM) : Free Stock Analysis Report
 
Agios Pharmaceuticals, Inc. (AGIO) : Free Stock Analysis Report
 
BrightView Holdings, Inc. (BV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research